Luminar Provides Business Update with Q4 and Full-Year 2022 Financials
Luminar (NASDAQ: LAZR) announced its fourth quarter and full year 2022 financial results, highlighting impressive growth and strategic advancements. The company achieved all four key milestones, including the start of production with Iris and major commercial wins, exceeding its 60% year-over-year growth targets. Looking ahead, Luminar anticipates exponential revenue acceleration with triple-digit growth in the coming years. The company is committed to achieving profitability in both the near and long term, indicating robust operational efficiency and a strong market position within the automotive technology sector.
- Achieved all four key milestones for 2022.
- Surpassed 60% year-over-year growth targets.
- Anticipates triple-digit revenue growth in the coming years.
- Commits to near-term and long-term profitability.
- None.
Providing Guidance for Near-term and Long-term Profitability;
Exponential Revenue Acceleration Anticipated with Triple-Digit Percentage Growth for Coming Years
“In 2022, we achieved or exceeded all four key company-level milestones including: achieving the start of production with Iris, advancing our software, and exceeding our previously raised sixty percent year-over-year growth targets for both major commercial wins and our forward-looking order book,” said
Today, the company also hosted Luminar Day at its headquarters, where it announced several new commercial agreements, revealed its new Iris+ sensor and reported positive industrialization progress, ahead of prior guidance, to meet the strong, forecasted customer demand. A replay of Luminar Day presentations is available at www.luminartech.com/day.
Key Q4 & Full-Year 2022 Financials:
Key financial highlights for the fourth-quarter and full-year ended
-
Revenue: Q4 revenue of
and full-year revenue of$11.1 million . Both are at the lower end of guidance range primarily due to timing of program and service revenue recognition.$40.7 million -
GAAP and Non-GAAP net loss: Q4 GAAP net loss was
, or$144.8 million per share; Q4 Non-GAAP net loss was$(0.40) , or$94.9 million per share, slightly higher than expectations as we invested in industrialization and ongoing software development. For the full year, GAAP net loss was$(0.26) , or$445.9 million per share; Non-GAAP net loss was$(1.25) , or$279.3 million per share.$(0.78) -
Cash,
Cash Equivalents and Marketable Securities : Cash position, including marketable securities, of as of$488.9 million December 31, 2022 , compared to as of$792.1 million December 31, 2021 . Net cash used in operating activities was in Q4 and$(74.7) million for the full year. Free Cash Flow (operating cash flow less capital expenditures) was$(208.2) million in Q4 and$(79.5) million for the full year. Net cash used in operating activities was higher and Free Cash Flow was lower sequentially from Q3 primarily due to operating loss from industrialization & software investments.$(226.3) million
Major 2023 Milestone Targets and Financial Guidance:
Today,
Top 3 Critical Business Milestones to Achieve by Year-End 2023:
-
Bring new high volume, automated manufacturing facility in
Mexico online and validate to Volvo’s series production requirements for global vehicle launches -
Execute Product and Technology Roadmap
- Enter Iris+ C-phase
- Build next-gen lidar prototype
- Complete software to support Volvo and Mercedes-Benz series production programs
-
Execute and Grow the Business
-
Add at least
to forward-looking Order Book in 2023$1 billion
-
Add at least
2023 Financial Outlook:
-
Revenue Growth: The company expects revenue growth of at least
100% in 2023 - Gross Margin: The company expects to reach positive gross margin by the fourth quarter
-
Cash,
Cash Equivalents and Marketable Securities (including liquidity): The company expects to end the year with a balance of greater than$300 million
Plan for Profitability:
At Luminar Day, the company unveiled its plan to achieve near-term as well as long-term profitability, with target metrics beginning this year.
For additional information or to be added to our investor distribution list, please visit us at https://investors.luminartech.com/news-events/email-alerts.
Non-GAAP Financial Measures and Other Metrics
In addition to disclosing financial measures prepared in accordance with
This release includes non-GAAP financial measures, including non-GAAP net loss and Free Cash Flow. Non-GAAP net loss is defined as GAAP net loss plus stock-based compensation expense, plus amortization of intangible assets, plus impairment of investments and certain other assets, plus legal reserve related to employee matters, plus transaction costs relating to acquisition activities, plus expenses related to registration statement on Form S-1 or Form S-3 on behalf of selling stockholders, plus change in fair value of warrant liabilities, plus provision for (benefit from) income taxes. Free Cash Flow is defined as operating cash flow less capital expenditures.
We use “Order Book” as a metric to measure performance against anticipated achievement of planned key milestones of our business. Order Book is defined as the forward-looking cumulative billings estimate of Luminar’s hardware and software products over the lifetime of given vehicle production programs which Luminar’s technology is expected to be integrated into or provided for, based primarily on projected / actual contractual pricing terms and our good faith estimates of “take rate” of Luminar’s technology on vehicles. “Take rates” are the anticipated percentage of new vehicles to be equipped with Luminar’s technology based on a combination of original equipment manufacturer (“OEM”) product offering decisions and predicted end consumer purchasing decisions. We include programs in our Order Book when (a) we have obtained a written agreement (e.g. non-binding expression of interest arrangement or an agreement for non-recurring engineering project) or public announcement with a major industry player, and (b) we expect to ultimately be awarded a significant commercial program.
We believe Order Book provides useful information to investors as a supplemental performance metric as our products are currently in a pre-production stage and therefore there are currently no billings or revenues from commercial grade product sales. OEMs customarily place non-cancelable purchase orders with their automotive component suppliers only shortly before or during production. Consequently, we use Order Book to inform investors about the progress of expected adoption of our technologies by OEMs because there is, in our view, no other better metric available at our stage. The Order Book estimate may be impacted by various factors, as described in “Risk Factors” in Item 1A of Part I of our Annual Report on Form 10-K for the fiscal year ended
(i) None of our customers make contractual commitments to use our lidar sensors and software until all test and validation activities have been completed, they have finalized plans for integrating our systems, have a positive expectation of the market demand for our features, and unrelated to us, have determined that their vehicle is ready for market and there is appropriate consumer demand. Consequently, there is no assurance or guarantee that any of our customers, including any programs which we included in our Order Book estimates will ever complete such testing and validation or enter into a definitive volume production agreement with us or that we will receive any billings or revenues forecasted in connection with such programs.
(ii) The development cycles of our products with new customers vary widely depending on the application, market, customer and the complexity of the product. In the automotive market, for example, this development cycle can be as long as seven or more years. Variability in development cycles make it difficult to reliably estimate the pricing, volume or timing of purchases of our products by our customers.
(iii) Customers cancel or postpone implementation of our technology.
(iv) We may not be able to integrate our technology successfully into a larger system with other sensing modalities.
(v) The product or vehicle model that is expected to include our lidar products may be unsuccessful, including for reasons unrelated to our technology.
These risks and uncertainties may cause our future actual sales to be materially different than that implied by the Order Book metric.
Forward-Looking Statements
Certain statements included in this press release that are not historical facts are forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as “aims,” “believe,” “may,” “will,” “estimate,” “set,” “continue,” “towards,” “anticipate,” “intend,” “expect,” “should,” “would,” “forward,” and similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding expected achievement and timing of manufacturing scale up, OEM production readiness, next-gen lidar prototype delivery, Iris+ program milestones and Order Book growth, and expectations for 2023 revenue growth, gross margin improvement, operating expense growth, year-end cash, cash equivalents and marketable securities (including liquidity) balance, and year-end share count. These statements are based on various assumptions, whether or not identified in this press release, and on the current expectations of Luminar’s management and are not guarantees of actual performance. Forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from the forward-looking statements, including the risks discussed in the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of Luminar’s most recently filed periodic reports on Form 10-K and Form 10-Q, and other documents
About
|
|||||||
Condensed Consolidated Balance Sheets |
|||||||
(In thousands) |
|||||||
(Unaudited) |
|||||||
|
|
||||||
|
2022 |
|
2021 |
||||
ASSETS |
|
|
|
||||
Current Assets: |
|
|
|
||||
Cash and cash equivalents |
$ |
69,552 |
|
|
$ |
329,977 |
|
Restricted cash |
|
1,553 |
|
|
|
725 |
|
Marketable securities |
|
419,314 |
|
|
|
462,141 |
|
Accounts receivable |
|
11,172 |
|
|
|
13,013 |
|
Inventory |
|
8,792 |
|
|
|
10,342 |
|
Prepaid expenses and other current assets |
|
44,203 |
|
|
|
29,195 |
|
Total current assets |
|
554,586 |
|
|
|
845,393 |
|
Property and equipment, net |
|
30,260 |
|
|
|
11,009 |
|
Operating lease right-of-use assets |
|
21,244 |
|
|
|
9,145 |
|
Intangible assets, net |
|
22,077 |
|
|
|
2,424 |
|
|
|
18,816 |
|
|
|
3,110 |
|
Other non-current assets |
|
40,344 |
|
|
|
12,455 |
|
Total assets |
$ |
687,327 |
|
|
$ |
883,536 |
|
|
|
|
|
||||
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) |
|
|
|
||||
Current liabilities: |
|
|
|
||||
Accounts payable |
$ |
18,626 |
|
|
$ |
14,419 |
|
Accrued and other current liabilities |
|
52,962 |
|
|
|
19,844 |
|
Operating lease liabilities |
|
5,953 |
|
|
|
4,735 |
|
Total current liabilities |
|
77,541 |
|
|
|
38,998 |
|
Warrant liabilities |
|
3,005 |
|
|
|
31,230 |
|
Convertible senior notes |
|
612,192 |
|
|
|
608,957 |
|
Operating lease liabilities, non-current |
|
16,989 |
|
|
|
5,768 |
|
Other non-current liabilities |
|
4,005 |
|
|
|
598 |
|
Total liabilities |
|
713,732 |
|
|
|
685,551 |
|
Stockholders’ equity (deficit): |
|
|
|
||||
Class A common stock |
|
29 |
|
|
|
27 |
|
Class B common stock |
|
10 |
|
|
|
10 |
|
Additional paid-in capital |
|
1,558,685 |
|
|
|
1,257,214 |
|
Accumulated other comprehensive loss |
|
(4,226 |
) |
|
|
(908 |
) |
|
|
(312,477 |
) |
|
|
(235,871 |
) |
Accumulated deficit |
|
(1,268,426 |
) |
|
|
(822,487 |
) |
Total stockholders’ equity (deficit) |
|
(26,405 |
) |
|
|
197,985 |
|
Total liabilities and stockholders’ equity (deficit) |
$ |
687,327 |
|
|
$ |
883,536 |
|
|
|||||||||||||||
Condensed Consolidated Statements of Operations |
|||||||||||||||
(In thousands, except share and per share data) |
|||||||||||||||
(Unaudited) |
|||||||||||||||
|
Three Months Ended |
|
Twelve Months Ended |
||||||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||||||
Revenue: |
|
|
|
|
|
|
|
||||||||
Products |
$ |
8,357 |
|
|
$ |
3,857 |
|
|
$ |
18,492 |
|
|
$ |
10,118 |
|
Services |
|
2,769 |
|
|
|
8,487 |
|
|
|
22,206 |
|
|
|
21,826 |
|
Total revenue |
|
11,126 |
|
|
|
12,344 |
|
|
|
40,698 |
|
|
|
31,944 |
|
Cost of sales: |
|
|
|
|
|
|
|
||||||||
Products |
|
14,816 |
|
|
|
9,369 |
|
|
|
61,985 |
|
|
|
23,484 |
|
Services |
|
12,910 |
|
|
|
10,469 |
|
|
|
38,998 |
|
|
|
22,608 |
|
Total cost of sales |
|
27,726 |
|
|
|
19,838 |
|
|
|
100,983 |
|
|
|
46,092 |
|
Gross loss |
|
(16,600 |
) |
|
|
(7,494 |
) |
|
|
(60,285 |
) |
|
|
(14,148 |
) |
Operating expenses: |
|
|
|
|
|
|
|
||||||||
Research and development |
|
64,925 |
|
|
|
29,048 |
|
|
|
185,283 |
|
|
|
88,861 |
|
Sales and marketing |
|
11,974 |
|
|
|
5,848 |
|
|
|
38,672 |
|
|
|
17,858 |
|
General and administrative |
|
47,178 |
|
|
|
28,572 |
|
|
|
158,162 |
|
|
|
93,685 |
|
Total operating expenses |
|
124,077 |
|
|
|
63,468 |
|
|
|
382,117 |
|
|
|
200,404 |
|
Loss from operations |
|
(140,677 |
) |
|
|
(70,962 |
) |
|
|
(442,402 |
) |
|
|
(214,552 |
) |
Other income (expense), net: |
|
|
|
|
|
|
|
||||||||
Change in fair value of warrant liabilities |
|
2,577 |
|
|
|
(3,477 |
) |
|
|
9,222 |
|
|
|
(26,126 |
) |
Impairment of investments and certain other assets |
|
(6,016 |
) |
|
|
— |
|
|
|
(6,016 |
) |
|
|
— |
|
Interest expense and other |
|
(2,007 |
) |
|
|
(1,168 |
) |
|
|
(11,095 |
) |
|
|
(2,028 |
) |
Interest income and other |
|
1,412 |
|
|
|
1,714 |
|
|
|
5,024 |
|
|
|
3,458 |
|
Total other income (expense), net |
|
(4,034 |
) |
|
|
(2,931 |
) |
|
|
(2,865 |
) |
|
|
(24,696 |
) |
Loss before provision for (benefit from) income taxes |
|
(144,711 |
) |
|
|
(73,893 |
) |
|
|
(445,267 |
) |
|
|
(239,248 |
) |
Provision for (benefit from) income taxes |
|
106 |
|
|
|
— |
|
|
|
672 |
|
|
|
(1,262 |
) |
Net loss |
$ |
(144,817 |
) |
|
$ |
(73,893 |
) |
|
$ |
(445,939 |
) |
|
$ |
(237,986 |
) |
Net loss per share: |
|
|
|
|
|
|
|
||||||||
Basic and diluted |
$ |
(0.40 |
) |
|
$ |
(0.21 |
) |
|
$ |
(1.25 |
) |
|
$ |
(0.69 |
) |
Shares used in computing net loss per share: |
|
|
|
|
|
|
|
||||||||
Basic and diluted |
|
363,996,601 |
|
|
|
359,483,729 |
|
|
|
356,265,774 |
|
|
|
346,300,975 |
|
|
|||||||
Condensed Consolidated Statements of Cash Flows |
|||||||
(In thousands) |
|||||||
(Unaudited) |
|||||||
|
Twelve Months Ended |
||||||
|
2022 |
|
2021 |
||||
Cash flows from operating activities: |
|
|
|
||||
Net loss |
$ |
(445,939 |
) |
|
$ |
(237,986 |
) |
Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
|
||||
Depreciation and amortization |
|
6,566 |
|
|
|
4,162 |
|
Amortization of operating lease right-of-use assets |
|
5,237 |
|
|
|
3,705 |
|
Amortization of premium on marketable securities |
|
1,288 |
|
|
|
1,792 |
|
Change in fair value of warrants |
|
(9,222 |
) |
|
|
26,126 |
|
Vendor stock-in-lieu of cash program |
|
41,459 |
|
|
|
10,817 |
|
Amortization of debt discount and issuance costs |
|
3,236 |
|
|
|
— |
|
Impairment of inventories |
|
12,154 |
|
|
|
2,918 |
|
Loss on sale or disposal of property and equipment |
|
— |
|
|
|
752 |
|
Share-based compensation |
|
162,405 |
|
|
|
77,684 |
|
Impairment of investments and other assets |
|
6,016 |
|
|
|
— |
|
Expense related to Volvo Warrants |
|
— |
|
|
|
959 |
|
Warranty related to sensors |
|
2,481 |
|
|
|
1,538 |
|
Deferred taxes |
|
232 |
|
|
|
(1,262 |
) |
Other |
|
— |
|
|
|
305 |
|
Changes in operating assets and liabilities: |
|
|
|
||||
Accounts receivable |
|
5,144 |
|
|
|
(6,233 |
) |
Inventories |
|
(10,477 |
) |
|
|
(10,751 |
) |
Prepaid expenses and other current assets |
|
(6,557 |
) |
|
|
(24,340 |
) |
Other non-current assets |
|
(3,289 |
) |
|
|
(6 |
) |
Accounts payable |
|
5,301 |
|
|
|
3,838 |
|
Accrued and other current liabilities |
|
17,768 |
|
|
|
3,578 |
|
Other non-current liabilities |
|
(2,035 |
) |
|
|
(6,017 |
) |
Net cash used in operating activities |
|
(208,232 |
) |
|
|
(148,421 |
) |
Cash flows from investing activities: |
|
|
|
||||
Acquisition of |
|
(2,759 |
) |
|
|
— |
|
Acquisition of certain assets from |
|
(2,001 |
) |
|
|
— |
|
Cash received from acquisition of |
|
— |
|
|
|
358 |
|
Purchases of marketable securities |
|
(404,598 |
) |
|
|
(716,933 |
) |
Proceeds from maturities of marketable securities |
|
367,367 |
|
|
|
366,857 |
|
Proceeds from sales/redemptions of marketable securities |
|
88,041 |
|
|
|
161,910 |
|
Purchases of property and equipment |
|
(15,614 |
) |
|
|
(6,433 |
) |
Disposal of property and equipment |
|
— |
|
|
|
53 |
|
Advances for capital projects and equipment |
|
(2,450 |
) |
|
|
— |
|
Net cash provided by (used in) investing activities |
|
27,986 |
|
|
|
(194,188 |
) |
Cash flows from financing activities: |
|
|
|
||||
Proceeds from issuance of convertible senior notes, net of debt discounts of |
|
— |
|
|
|
609,375 |
|
Purchases of capped call options |
|
— |
|
|
|
(73,438 |
) |
Repayment of debt |
|
— |
|
|
|
(112 |
) |
Principal payments on finance leases (capital leases prior to adoption of ASC 842) |
|
— |
|
|
|
(289 |
) |
Proceeds from exercise of warrants |
|
— |
|
|
|
153,927 |
|
Proceeds from exercise of stock options |
|
3,986 |
|
|
|
5,859 |
|
Proceeds from sale of Class A common stock under ESPP |
|
1,271 |
|
|
|
— |
|
Payments of employee taxes related to stock-based awards |
|
(3,730 |
) |
|
|
— |
|
Repurchases of common stock and redemption of warrants |
|
(80,878 |
) |
|
|
(231,600 |
) |
Other financing activities |
|
— |
|
|
|
(130 |
) |
Net cash provided by (used in) financing activities |
|
(79,351 |
) |
|
|
463,592 |
|
Net increase (decrease) in cash, cash equivalents and restricted cash |
|
(259,597 |
) |
|
|
120,983 |
|
Beginning cash, cash equivalents and restricted cash |
|
330,702 |
|
|
|
209,719 |
|
Ending cash, cash equivalents and restricted cash |
$ |
71,105 |
|
|
$ |
330,702 |
|
|
|||||||||||||||
Reconciliation of GAAP Cost of Sales to Non-GAAP Cost of Sales |
|||||||||||||||
(In thousands) |
|||||||||||||||
(Unaudited) |
|||||||||||||||
|
Three Months Ended |
|
Twelve Months Ended |
||||||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||||||
GAAP cost of sales |
$ |
27,726 |
|
|
$ |
19,838 |
|
|
$ |
100,983 |
|
|
$ |
46,092 |
|
Non-GAAP adjustments: |
|
|
|
|
|
|
|
||||||||
Stock-based compensation |
|
6,525 |
|
|
|
(3,593 |
) |
|
|
(7,680 |
) |
|
|
(6,422 |
) |
Amortization of intangible assets |
|
(166 |
) |
|
|
(29 |
) |
|
|
(635 |
) |
|
|
(48 |
) |
Non-GAAP cost of sales |
$ |
34,085 |
|
|
$ |
16,216 |
|
|
$ |
92,668 |
|
|
$ |
39,622 |
|
|
|||||||||||||||
Reconciliation of GAAP Gross Loss to Non-GAAP Gross Loss |
|||||||||||||||
(In thousands) |
|||||||||||||||
(Unaudited) |
|||||||||||||||
|
Three Months Ended |
|
Twelve Months Ended |
||||||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||||||
GAAP gross loss |
$ |
(16,600 |
) |
|
$ |
(7,494 |
) |
|
$ |
(60,285 |
) |
|
$ |
(14,148 |
) |
Non-GAAP adjustments: |
|
|
|
|
|
|
|
||||||||
Stock-based compensation |
|
(6,525 |
) |
|
|
3,593 |
|
|
|
7,680 |
|
|
|
6,422 |
|
Amortization of intangible assets |
|
166 |
|
|
|
29 |
|
|
|
635 |
|
|
|
48 |
|
Non-GAAP gross loss |
$ |
(22,959 |
) |
|
$ |
(3,872 |
) |
|
$ |
(51,970 |
) |
|
$ |
(7,678 |
) |
|
|||||||||||||||
Reconciliation of GAAP Operating Expenses to Non-GAAP Operating Expenses |
|||||||||||||||
(In thousands) |
|||||||||||||||
(Unaudited) |
|||||||||||||||
|
Three Months Ended |
|
Twelve Months Ended |
||||||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||||||
GAAP operating expenses |
$ |
124,077 |
|
|
$ |
63,468 |
|
|
$ |
382,117 |
|
|
$ |
200,404 |
|
Non-GAAP adjustments: |
|
|
|
|
|
|
|
||||||||
Stock-based compensation |
|
(51,056 |
) |
|
|
(24,204 |
) |
|
|
(154,725 |
) |
|
|
(71,262 |
) |
Amortization of intangible assets |
|
(525 |
) |
|
|
(35 |
) |
|
|
(1,602 |
) |
|
|
(178 |
) |
Reserve related to employee matters |
|
(1,100 |
) |
|
|
— |
|
|
|
(3,100 |
) |
|
|
— |
|
Transaction costs relating to acquisition activities |
|
(192 |
) |
|
|
— |
|
|
|
(1,955 |
) |
|
|
— |
|
Expenses related to registration statement on Form S-1 or Form S-3 on behalf of selling stockholders |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(1,982 |
) |
Non-GAAP operating expenses |
$ |
71,204 |
|
|
$ |
39,229 |
|
|
$ |
220,735 |
|
|
$ |
126,982 |
|
|
|||||||||||||||
Reconciliation of GAAP Net Loss to Non-GAAP Net Loss |
|||||||||||||||
(In thousands, except share and per share data) |
|||||||||||||||
(Unaudited) |
|||||||||||||||
|
Three Months Ended |
|
Twelve Months Ended |
||||||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||||||
GAAP net loss |
$ |
(144,817 |
) |
|
$ |
(73,893 |
) |
|
$ |
(445,939 |
) |
|
$ |
(237,986 |
) |
Non-GAAP adjustments: |
|
|
|
|
|
|
|
||||||||
Stock-based compensation |
|
44,531 |
|
|
|
27,797 |
|
|
|
162,405 |
|
|
|
77,684 |
|
Amortization of intangible assets |
|
691 |
|
|
|
64 |
|
|
|
2,237 |
|
|
|
226 |
|
Impairment of investments and certain other assets |
|
6,002 |
|
|
|
— |
|
|
|
6,002 |
|
|
|
— |
|
Legal reserve related to employee matters |
|
1,100 |
|
|
|
— |
|
|
|
3,100 |
|
|
|
— |
|
Transaction costs relating to acquisition activities |
|
192 |
|
|
|
— |
|
|
|
1,955 |
|
|
|
— |
|
Expenses related to registration statement on Form S-1 or Form S-3 on behalf of selling stockholders |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1,982 |
|
Change in fair value of warrant liabilities |
|
(2,577 |
) |
|
|
3,477 |
|
|
|
(9,222 |
) |
|
|
26,126 |
|
Provision for (benefit from) income taxes |
|
— |
|
|
|
— |
|
|
|
165 |
|
|
|
(1,262 |
) |
Non-GAAP net loss |
$ |
(94,878 |
) |
$ |
(42,555 |
) |
|
$ |
(279,297 |
) |
|
$ |
(133,230 |
) |
|
GAAP net loss per share: |
|
|
|
|
|
|
|
||||||||
Basic and diluted |
$ |
(0.40 |
) |
|
$ |
(0.21 |
) |
|
$ |
(1.25 |
) |
|
$ |
(0.69 |
) |
Non-GAAP net loss per share: |
|
|
|
|
|
|
|
||||||||
Basic and diluted |
$ |
(0.26 |
) |
|
$ |
(0.12 |
) |
|
$ |
(0.78 |
) |
|
$ |
(0.38 |
) |
Shares used in computing GAAP net loss per share: |
|
|
|
|
|
|
|
||||||||
Basic and diluted |
|
363,996,601 |
|
|
|
359,483,729 |
|
|
|
356,265,774 |
|
|
|
346,300,975 |
|
Shares used in computing Non-GAAP net loss per share: |
|
|
|
|
|
|
|
||||||||
Basic and diluted |
|
363,996,601 |
|
|
|
359,483,729 |
|
|
|
356,265,774 |
|
|
|
346,300,975 |
|
|
|||||||
Reconciliation of GAAP Operating Cash Flow to Non-GAAP Free Cash Flow |
|||||||
(In thousands) |
|||||||
(Unaudited) |
|||||||
|
Twelve Months Ended |
||||||
|
2022 |
|
2021 |
||||
GAAP operating cash flow |
$ |
(208,232 |
) |
|
$ |
(148,421 |
) |
Non-GAAP adjustments: |
|
|
|
||||
Capital expenditures |
|
(18,064 |
) |
|
|
(6,433 |
) |
Non-GAAP free cash flow |
$ |
(226,296 |
) |
|
$ |
(154,854 |
) |
|
||||||||||||
Summary of Stock-Based Compensation and Intangibles Amortization |
||||||||||||
(In thousands) |
||||||||||||
(Unaudited) |
||||||||||||
|
Three Months Ended |
|||||||||||
|
2022 |
|
2021 |
|||||||||
|
Stock-Based
|
|
Intangibles
|
|
Stock-Based
|
|
Intangibles
|
|||||
Cost of Sales |
$ |
(6,525 |
) |
|
$ |
166 |
|
$ |
3,593 |
|
$ |
29 |
Research and development |
|
13,756 |
|
|
|
192 |
|
|
7,473 |
|
|
15 |
Sales and marketing |
|
6,384 |
|
|
|
333 |
|
|
1,567 |
|
|
20 |
General and administrative |
|
30,916 |
|
|
|
— |
|
|
15,164 |
|
|
— |
Total |
$ |
44,531 |
|
|
$ |
691 |
|
$ |
27,797 |
|
$ |
64 |
|
Twelve Months Ended |
||||||||||
|
2022 |
|
2021 |
||||||||
|
Stock-Based
|
|
Intangibles
|
|
Stock-Based
|
|
Intangibles
|
||||
Cost of Sales |
$ |
7,680 |
|
$ |
635 |
|
$ |
6,422 |
|
$ |
48 |
Research and development |
|
40,898 |
|
|
585 |
|
|
20,216 |
|
|
25 |
Sales and marketing |
|
15,814 |
|
|
1,017 |
|
|
4,546 |
|
|
153 |
General and administrative |
|
98,013 |
|
|
— |
|
|
46,500 |
|
|
— |
Total |
$ |
162,405 |
|
$ |
2,237 |
|
$ |
77,684 |
|
$ |
226 |
View source version on businesswire.com: https://www.businesswire.com/news/home/20230228006227/en/
Media Relations:
Press@luminartech.com
Investor Relations:
trey.campbell@luminartech.com
Source:
FAQ
What were Luminar's financial results for Q4 2022?
What milestones did Luminar achieve in 2022?
What is Luminar's revenue growth forecast?